Correlation Between Protect Pharmaceutical and FTAI Infrastructure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protect Pharmaceutical and FTAI Infrastructure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protect Pharmaceutical and FTAI Infrastructure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protect Pharmaceutical and FTAI Infrastructure, you can compare the effects of market volatilities on Protect Pharmaceutical and FTAI Infrastructure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protect Pharmaceutical with a short position of FTAI Infrastructure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protect Pharmaceutical and FTAI Infrastructure.

Diversification Opportunities for Protect Pharmaceutical and FTAI Infrastructure

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Protect and FTAI is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Protect Pharmaceutical and FTAI Infrastructure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FTAI Infrastructure and Protect Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protect Pharmaceutical are associated (or correlated) with FTAI Infrastructure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FTAI Infrastructure has no effect on the direction of Protect Pharmaceutical i.e., Protect Pharmaceutical and FTAI Infrastructure go up and down completely randomly.

Pair Corralation between Protect Pharmaceutical and FTAI Infrastructure

Given the investment horizon of 90 days Protect Pharmaceutical is expected to under-perform the FTAI Infrastructure. In addition to that, Protect Pharmaceutical is 3.04 times more volatile than FTAI Infrastructure. It trades about -0.03 of its total potential returns per unit of risk. FTAI Infrastructure is currently generating about -0.01 per unit of volatility. If you would invest  885.00  in FTAI Infrastructure on August 29, 2024 and sell it today you would lose (19.00) from holding FTAI Infrastructure or give up 2.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Protect Pharmaceutical  vs.  FTAI Infrastructure

 Performance 
       Timeline  
Protect Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Protect Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
FTAI Infrastructure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FTAI Infrastructure has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, FTAI Infrastructure is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Protect Pharmaceutical and FTAI Infrastructure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protect Pharmaceutical and FTAI Infrastructure

The main advantage of trading using opposite Protect Pharmaceutical and FTAI Infrastructure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protect Pharmaceutical position performs unexpectedly, FTAI Infrastructure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FTAI Infrastructure will offset losses from the drop in FTAI Infrastructure's long position.
The idea behind Protect Pharmaceutical and FTAI Infrastructure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments